Spontaneous regression of optic gliomas: thirteen cases documented by serial neuro imaging
Arch Ophthalmol 2001 Apr;119(4):516-29
Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro ML, McFadzean RM, Rubtsova IV, Hoyt WF.
Long-term visual outcome in patients with anterior visual pathway gliomas
Journal of Neuroophthalmology 2001 Mar;21(1):1-7
Gayre GS, Scott IU, Feuer W, Saunders TG, Siatkowski RM.
When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre.
European Journal of Pediatrics, 2000 Sep;159(9):692-6
Grill J, Laithier V, Rodriguez D, Raquin MA, Pierre-Kahn A, Kalifa C.
Early spontaneous regression of a hypothalamic/chiasmatic mass in neurofibromatosis type 1: MR findings.
Eur Radiol 2000;10(7):1076-8
Zuccoli G, Ferrozzi F, Sigorini M, Virdis R, Bassi P, Bellomi M.
Carboplatin therapy for optic pathway tumors in children with neurofibromatosis type-1.
Journal of Neurooncology 1999;45(2):185-90
Intracranial gliomas in neurofibromatosis type 1
American Journal of Medical Genetics 1999 Mar 26;89(1):38-44
Listernick R, Charrow J, Gutmann DH.
Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA